X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1560) 1560
amoxicillin-potassium clavulanate combination - therapeutic use (1128) 1128
female (954) 954
male (948) 948
anti-bacterial agents - therapeutic use (893) 893
adult (543) 543
drug therapy, combination - therapeutic use (527) 527
middle aged (502) 502
amoxicillin - therapeutic use (475) 475
amoxicillin-potassium clavulanate combination (435) 435
index medicus (413) 413
aged (384) 384
clavulanic acids - therapeutic use (381) 381
child (335) 335
treatment outcome (327) 327
infectious diseases (291) 291
adolescent (289) 289
child, preschool (283) 283
acute disease (245) 245
microbiology (239) 239
infant (221) 221
amoxicillin-potassium clavulanate combination - administration & dosage (209) 209
antibiotics (208) 208
pharmacology & pharmacy (205) 205
anti-bacterial agents - administration & dosage (191) 191
prospective studies (181) 181
microbial sensitivity tests (165) 165
amoxicillin (157) 157
amoxicillin-potassium clavulanate combination - adverse effects (157) 157
double-blind method (143) 143
bacterial infections - drug therapy (138) 138
aged, 80 and over (136) 136
administration, oral (134) 134
medicine, general & internal (134) 134
pediatrics (134) 134
animals (130) 130
children (129) 129
otitis media - drug therapy (126) 126
cephalosporins - therapeutic use (123) 123
drug therapy, combination (123) 123
drug therapy, combination - administration & dosage (123) 123
amoxicillin - administration & dosage (114) 114
drug therapy, combination - adverse effects (112) 112
anti-bacterial agents - adverse effects (111) 111
surgery (110) 110
amoxicillin-potassium clavulanate combination - pharmacology (108) 108
anti-bacterial agents - pharmacology (108) 108
infections (104) 104
management (101) 101
clavulanic acids - administration & dosage (99) 99
drug combinations - therapeutic use (99) 99
follow-up studies (99) 99
risk factors (97) 97
respiratory tract infections - drug therapy (95) 95
amoxicillin - adverse effects (94) 94
time factors (94) 94
retrospective studies (91) 91
anti-infective agents - therapeutic use (89) 89
metronidazole - therapeutic use (89) 89
drug administration schedule (88) 88
urinary tract infections - drug therapy (87) 87
health aspects (85) 85
clavulanic acids - adverse effects (80) 80
dentistry, oral surgery & medicine (76) 76
recurrence (76) 76
immunology (75) 75
therapy (75) 75
drug therapy (74) 74
sinusitis - drug therapy (73) 73
tomography, x-ray computed (73) 73
diagnosis (72) 72
infection (71) 71
community-acquired infections - drug therapy (70) 70
ciprofloxacin - therapeutic use (69) 69
diagnosis, differential (69) 69
antibiotic prophylaxis (68) 68
streptococcus pneumoniae - drug effects (68) 68
young adult (68) 68
drug resistance, bacterial (67) 67
clavulanic acid (66) 66
surgical wound infection - prevention & control (66) 66
amoxicillin/clavulanate (62) 62
pneumonia, bacterial - drug therapy (62) 62
cefuroxime - therapeutic use (61) 61
otorhinolaryngology (58) 58
chronic disease (57) 57
efficacy (57) 57
bronchitis - drug therapy (55) 55
care and treatment (55) 55
penicillins - therapeutic use (55) 55
randomized controlled trials as topic (55) 55
resistance (54) 54
combined modality therapy (53) 53
abridged index medicus (52) 52
azithromycin - therapeutic use (52) 52
escherichia coli infections - drug therapy (52) 52
trimethoprim, sulfamethoxazole drug combination - therapeutic use (52) 52
pharmacokinetics (51) 51
gentamicins - therapeutic use (50) 50
pneumonia (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1355) 1355
French (103) 103
Spanish (62) 62
Russian (42) 42
German (33) 33
Japanese (17) 17
Dutch (11) 11
Italian (9) 9
Hungarian (5) 5
Polish (5) 5
Czech (4) 4
Turkish (4) 4
Bulgarian (3) 3
Romanian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2002, Volume 35, Issue 4, pp. 381 - 389
This study tested whether levofloxacin, at a new high dose of 750 mg, was effective for the treatment of complicated skin and skin-structure infections... 
Osteomyelitis | Pathogens | Diabetes complications | Major Articles | Antimicrobials | Ulcers | Aerobic bacteria | Infections | Skin | Diabetes | Dosage | UNCOMPLICATED SKIN | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | MULTICENTER | SAFETY | MICROBIOLOGY | PHARMACODYNAMICS | IMMUNOLOGY | PHARMACOKINETICS | DOUBLE-BLIND | 750-MILLIGRAM | HEALTHY-VOLUNTEERS | CIPROFLOXACIN | Levofloxacin | Humans | Middle Aged | Ofloxacin - therapeutic use | Ticarcillin - adverse effects | Male | Drug Therapy, Combination - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Clavulanic Acids - adverse effects | Ofloxacin - adverse effects | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Ofloxacin - administration & dosage | Female | Anti-Infective Agents - adverse effects | Ticarcillin - administration & dosage | Clavulanic Acids - administration & dosage | Anti-Infective Agents - therapeutic use | Clavulanic Acids - therapeutic use | Skin Diseases - drug therapy | Treatment Outcome | Drug Therapy, Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Anti-Infective Agents - administration & dosage | Drug Therapy, Combination - administration & dosage | Ticarcillin - therapeutic use | Infection | Evaluation | Amoxicillin | Ticarcillin | Clavulanate
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2012, Volume 54, Issue 2, pp. 167 - 174
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2013, Volume 57, Issue 6, pp. 2506 - 2510
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MEROPENEM-CLAVULANATE | CARBAPENEMS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MOXIFLOXACIN | INFECTION MODEL | DRUG-RESISTANT TUBERCULOSIS | DISCOVERY | Tuberculosis, Pulmonary - microbiology | beta-Lactams - pharmacokinetics | Clavulanic Acid - administration & dosage | Humans | Thienamycins - pharmacokinetics | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Microbial Sensitivity Tests - standards | Female | Drug Therapy, Combination | Disease Models, Animal | Thienamycins - therapeutic use | Thienamycins - administration & dosage | Clavulanic Acid - pharmacology | Streptomycin - pharmacology | Treatment Outcome | Clavulanic Acid - pharmacokinetics | Thienamycins - pharmacology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | beta-Lactams - pharmacology | Animals | Amoxicillin-Potassium Clavulanate Combination - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Mycobacterium tuberculosis - growth & development | Experimental Therapeutics
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2017, Volume 72, Issue 7, pp. 1911 - 1914
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 8/2007, Volume 60, Issue 2, pp. 370 - 376
Objectives Complicated skin and skin structure infections (cSSSIs), including diabetic foot infections (DFIs), are often polymicrobial, requiring combination... 
Fluoroquinolones | β-lactam inhibitors | Penicillins | Complicated skin and skin structure infections | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | ANTIMICROBIAL AGENTS | MICROBIOLOGY | complicated skin and skin structure infections | COMPLICATED SKIN | MULTICENTER TRIAL | SKIN-STRUCTURE INFECTIONS | beta-lactam inhibitors | ANAEROBIC-BACTERIA | PHARMACOLOGY & PHARMACY | OPEN-LABEL TRIAL | AMOXICILLIN-CLAVULANATE | fluoroquinolones | penicillins | IN-VITRO ACTIVITY | Aza Compounds - therapeutic use | Humans | Aza Compounds - adverse effects | Male | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Penicillanic Acid - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Penicillanic Acid - adverse effects | Bacterial Infections - microbiology | Penicillanic Acid - analogs & derivatives | Databases, Factual | Double-Blind Method | Bacterial Infections - drug therapy | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Bacterial Infections - surgery | Diabetic Foot - microbiology | Piperacillin - adverse effects | Aged | Quinolines - therapeutic use | Quinolines - adverse effects | Piperacillin - therapeutic use | Skin diseases | Chemotherapy | Infections | Diabetes | Microbiology | Feet
Journal Article